EMA committee endorses Takeda dengue vaccine candidate
Takeda’s dengue vaccine candidate has been recommended for approval by an EMA commitee.
Archives for October 17, 2022
FDA pushes back decision date for motor-neuron disease drug Tofersen
The US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for Biogen’s tofersen: with a decision now expected in April next year.
Charles River looks to speed up viral vector manufacturing
Charles River Laboratories International has launched a new AAV based platform that it claims has the capability to reduce time from process development to GMP by 55% and deliver a drug product in fewer than eight months.